Report: Advancing Global Health Innovation Through Europe-Africa Collaboration

Today, Medicines Development for Global Health joined seven Product Development Partnerships (PDPs) to call for sustained investment in the European and Developing Countries Clinical Trials Partnership (EDCTP) under the next EU Framework Programme for Research and Innovation (FP10) and other EU funding frameworks.

For more than 20 years, EDCTP has demonstrated the impact of Europe-Africa collaboration, supporting clinical research, strengthening scientific capacity and accelerating the development of health technologies that address poverty-related neglected diseases. Since 2003 and across its three programmes, EDCTP has delivered nine licensed medical interventions, supported over 600 clinical studies and produced over 2,000 peer-reviewed publications.¹

Beyond its role as a research funding instrument, EDCTP serves as a strategic platform connecting Europe’s global health, research and innovation agendas.

As global health challenges evolve, continued investment in EDCTP will be essential to ensure Europe and Africa remain at the forefront of discovery, innovation and preparedness for ongoing and emerging threats.

Read more about the impact of the collaboration between PDPs and EDCTP in this newly launched report [Click here].

-End